Related Experiment Video
Updated: May 19, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression
Junye Liu1, Le Yang, Jian Zhang
1Department of Radiation Medicine, Fourth Military Medical University, Xi'an, China.
Background:
NDRG2, a member of N-Myc downstream regulated gene family, plays some roles in cellular stress, cell differentiation and tumor suppression. We have found that NDRG2 expression in cervical cancer Hela cells increases significantly upon stimulation with cisplatin, the most popular chemotherapeutic agent currently used for the treatment of advanced cervical cancer. This interesting phenomenon drove us to evaluate the role of NDRG2 in chemosensitivity of Hela cells.
Methods:
In the present study, RNA interference was employed to down-regulate NDRG2 expression in Hela cells. RT-PCR and Western blot were used to detect expression of NDRG2, Bcl-2 and Bax in cancer cells. Real-time PCR was applied to detect miR-15b and miR-16 expression levels. Drug sensitivity was determined with MTT assay. Cell cloning efficiency was evaluated by Colony-forming assay. Apoptotic cells were detected with annexin V staining and flow cytometry.
Results:
In vitro drug sensitivity assay revealed that suppression of NDRG2 could sensitize Hela cells to cisplatin. Down-regulation of NDRG2 didn't influence the colony-forming ability but promoted cisplatin-induced apoptosis of Hela cells. Inhibition of NDRG2 in Hela cells was accompanied by decreased Bcl-2 protein level. However, Bcl-2 mRNA level was not changed in Hela cells with down-regulation of NDRG2. Further study indicated that miR-15b and miR-16, two microRNAs targetting Bcl-2, were significantly up-regulated in NDRG2-suppressed Hela cells.
Conclusions:
These data suggested that down-regulation of NDRG2 could enhance sensitivity of Hela cells to cisplatin through inhibiting Bcl-2 protein expression, which might be mediated by up-regulating miR-15b and miR-16.
Insights
Down-regulating NDRG2 (N-Myc downstream regulated gene 2) enhances cervical cancer Hela cells' sensitivity to cisplatin chemotherapy. This occurs by increasing apoptosis via the miR-15b/miR-16 pathway, which downregulates Bcl-2 protein expression.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- NDRG2 (N-Myc downstream regulated gene 2) is implicated in stress response, differentiation, and tumor suppression.
- NDRG2 expression significantly increases in cervical cancer Hela cells treated with cisplatin.
- This observation prompted an investigation into NDRG2's role in Hela cell chemosensitivity.
Purpose of the Study:
- To evaluate the role of NDRG2 in cisplatin chemosensitivity of cervical cancer Hela cells.
- To elucidate the molecular mechanisms underlying NDRG2's influence on chemosensitivity.
- To determine if NDRG2 modulation affects cisplatin-induced apoptosis and related protein expression.
Main Methods:
- RNA interference was used to down-regulate NDRG2 expression in Hela cells.
- RT-PCR and Western blot analyzed NDRG2, Bcl-2, and Bax expression.
- Real-time PCR quantified miR-15b and miR-16 levels.
- MTT assays assessed drug sensitivity, colony-forming assays evaluated cloning efficiency, and flow cytometry detected apoptosis.
Main Results:
- Suppression of NDRG2 sensitized Hela cells to cisplatin in vitro.
- NDRG2 down-regulation promoted cisplatin-induced apoptosis without affecting colony-forming ability.
- Inhibition of NDRG2 led to decreased Bcl-2 protein levels, but not mRNA levels.
- miR-15b and miR-16 were significantly up-regulated in NDRG2-suppressed Hela cells.
Conclusions:
- Down-regulation of NDRG2 enhances Hela cell sensitivity to cisplatin.
- This sensitization is mediated by the inhibition of Bcl-2 protein expression.
- Upregulation of miR-15b and miR-16 likely mediates the observed effects on Bcl-2.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Abnormal Proliferation